| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $90 | $26.5K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 140 | $130 | $17.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $60 | $17.6K |
| J0897 | Injection, denosumab, 1 mg | 960 | $20 | $17.3K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 50 | $130 | $6K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 80 | $70 | $5.8K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | $160 | $3.9K |
| G0008 | Administration of influenza virus vaccine | 90 | $30 | $2.6K |
| 99495 | The provider manages the care of a patient during the transition to home care after discharge from a healthcare facility. The patient’s care requires at least moderate medical decision making,… | 20 | $160 | $2.6K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 50 | $40 | $1.8K |